Vigil Neuroscience Inc. (VIGL) NASDAQ
$3.20 - (-)
Market Cap: $118.03M
As of 03/27/24 12:00 AM EDT. Market open.
Vigil Neuroscience Inc. (VIGL)
NASDAQ
$3.20
- (-)
Market Cap: $118.03M
As of 03/27/24 12:00 AM EDT. Market open.
vigil neuroscience is the world’s first microglia-focused therapeutics company. our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. we are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based ... read more
vigil neuroscience is the world’s first microglia-focused therapeutics company. our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. we are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Magovcevic-Liebisch Ivana | President and CEO | Nov 20, 2023 | Buy | $3.75 | 4,000 | 15,000 | 207,687 | Nov 20, 2023, 06:34 PM |
Papapetropoulos Spyros | Chief Medical Officer | Nov 18, 2022 | Option Exercise | $1.89 | 300 | 567 | 4,300 | Nov 22, 2022, 09:45 PM |
Papapetropoulos Spyros | Chief Medical Officer | Nov 18, 2022 | Sale | $14.00 | 300 | 4,200 | 4,000 | Nov 22, 2022, 09:45 PM |
Thorp Clay | Director | May 17, 2022 | Buy | $2.97 | 14,893 | 44,189 | 1,556,030 | May 17, 2022, 09:06 PM |
Thorp Clay | Director | May 16, 2022 | Buy | $2.76 | 21,802 | 60,221 | 1,541,137 | May 17, 2022, 09:06 PM |
Thackaberry Evan | SVP, Head of Early Development | May 05, 2022 | Buy | $4.00 | 1,500 | 6,000 | 1,500 | May 06, 2022, 07:00 AM |
Verni Christopher | General Counsel | May 03, 2022 | Buy | $3.77 | 4,000 | 15,074 | 4,000 | May 04, 2022, 07:00 AM |
Magovcevic-Liebisch Ivana | President and CEO | May 03, 2022 | Buy | $3.94 | 1,000 | 3,940 | 203,687 | May 04, 2022, 07:00 AM |
Magovcevic-Liebisch Ivana | President and CEO | May 02, 2022 | Buy | $3.61 | 4,000 | 14,439 | 202,687 | May 04, 2022, 07:00 AM |
Ziolkowski Jennifer Lynn | Chief Financial Officer | May 03, 2022 | Buy | $3.77 | 4,000 | 15,098 | 4,000 | May 04, 2022, 07:00 AM |
Papapetropoulos Spyros | Chief Medical Officer | May 03, 2022 | Buy | $3.40 | 4,000 | 13,591 | 4,000 | May 04, 2022, 07:00 AM |
Thorp Clay | Director | Mar 28, 2022 | Buy | $7.20 | 3,000 | 21,604 | 3,000 | Mar 28, 2022, 04:44 PM |
Thorp Clay | Director | Jan 11, 2022 | Buy | $14.00 | 265,000 | 3,710,000 | 1,519,335 | Jan 11, 2022, 09:20 PM |
Vida Ventures GP III, L.L.C. | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 3,852 | 53,928 | 11,536 | Jan 11, 2022, 09:18 PM |
Vida Ventures GP III, L.L.C. | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 1,671,148 | 23,396,072 | 5,004,393 | Jan 11, 2022, 09:18 PM |
Atlas Venture Fund XII, L.P. | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 535,000 | 7,490,000 | 4,808,896 | Jan 11, 2022, 09:15 PM |
Booth Bruce | Director | Jan 11, 2022 | Buy | $14.00 | 535,000 | 7,490,000 | 4,808,896 | Jan 11, 2022, 09:11 PM |
Vitorovic Stefan | Director | Jan 11, 2022 | Buy | $14.00 | 3,852 | 53,928 | 11,536 | Jan 11, 2022, 09:11 PM |
Vitorovic Stefan | Director | Jan 11, 2022 | Buy | $14.00 | 1,671,148 | 23,396,072 | 5,004,393 | Jan 11, 2022, 09:11 PM |
Northpond Ventures GP, LLC | 10% Owner | Jan 11, 2022 | Buy | $14.00 | 355,000 | 4,970,000 | 1,382,978 | Jan 11, 2022, 08:18 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,173,523 | 0.07% | -35.78% | Other |
BLACKROCK INC. | 919,132 | 0.00008% | 8.48% | Other |
ORBIMED ADVISORS LLC | 448,891 | 0.03% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 315,538 | 0.00011% | 3.4% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View